无ST段抬高的急性冠状动脉综合症患者肌钙蛋白Ⅰ测定的临床意义  

The clinical significance on measure of troponin Ⅰin patlents of actue coronary syndrome with non-ST-segment elevation

作　　者：潘景会 孟宪刚 

机构地区：[1]山东省阳谷县人民医院心内科,252300

出　　处：《实用心脑肺血管病杂志》2005年第2期69-70,共2页Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease

摘　　要：目的探讨血清肌钙蛋白Ⅰ(cTnⅠ)对无ST段抬高的急性冠状动脉综合症(ACS)患者危险判断的临床意义。方法56例无ST段抬高的ACS患者进行了cTnⅠ测定,并观察1个月内心脏事件发生情况。结果56例无ST段抬高的ACS患者,在一个月内cTnⅠ值增高(≥1.5μg/L)者24例。cTnⅠ增高者发生心性死亡、急性ST段抬高心肌梗死、需介入或搭桥术者明显高于cTnⅠ<1.5μg/L者,并有统计学意义(P<0.05)。结论血清cTnI检测对无ST段抬高ASC患者病情发展的评估具有一定的判断价值。Objective To evaluate the clinical significance of serum troponin Ⅰ(cTnⅠ) in patients with non-ST-segment elevation of acute coronary syndrome(ACS). Methods Serum cTnⅠ levels were measured in 56 patients of ACS with non-ST-segment elevation.Cardiac events would be observed in 1 month. Results 24 patients cTnⅠ levels elevated.Among them the cardiac events that included cardiac sudden death and acute myocardial infarction,interventional treatment or coronary bypass were significantly higher than the normal cTnⅠ(P<0.05) in a month. Conclusion The detection of serum cTnⅠ could evaluate development of ACS patients with the non-ST-segment elevation.

关 键 词：肌钙蛋白Ⅰ 急性冠状动脉综合症 心肌梗死 ST段抬高 

分 类 号：R542.22[医药卫生—心血管疾病]